Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pfizer discovers potent, selective beta3-adrenoceptor full agonist

April 22, 1997

Astra Arcus develops selective CCK-A agonist with potential for obesity

April 22, 1997

First launch for Lipobay

April 22, 1997

ACAT inhibitors from Nihon Nohyaku

April 22, 1997

Cholesterol biosynthesis inhibitors described by Nippon Soda

April 21, 1997

Teijin and Microbial Chemistry Research Foundation reveal acetyl-CoA carboxylase inhibitor

April 21, 1997

Novavax completes phase Ia trial of generic human testosterone drug

April 21, 1997

Antidiabetic coumarin derivatives from Otsuka

April 21, 1997

Alteon reports positive results from phase II trials with pimagedine

April 18, 1997

Atorvastatin available in Germany for hyperlipidemia

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026